COVID-19 Severity in Multiple SclerosisMaria Pia Sormani, Giovanna Borriello, Gıancarlo Comı et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 74
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple SclerosisDamiano Baroncini, Diana Ferraro, Marta Simone et al.|JAMA Neurology|2021Cited by 62
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Laura Brambilla, Irene Schiavetti et al.|Multiple Sclerosis Journal|2021Cited by 52
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, Roberto Bergamaschi, Pietro Annovazzi et al.|Journal of Neurology|2018Cited by 35
Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosisVittorio Mantero, Christian Cordano, Damiano Baroncini et al.|Journal of Neurology|2020Cited by 26